Pharmaceutical

Grit Biotechnology secures funds for development of pipeline programmes

Grit Biotechnology has secured more than $60m in a Series B funding round to support the development of its pipeline programmes.

Sep 11, 2023 - 20:00
Grit Biotechnology secures funds for development of pipeline programmes
Grit Biotechnology has secured more than $60m in a Series B funding round to support the development of its pipeline programmes.
Read the original article

Tags:

Previous Article

Coherus acquires immuno-oncology company Surface

Next Article

Biosyngen receives FDA approval to start Phase I trial for TCR therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff

Opinion: Without a plan to fight superbugs, the Cancer ...

Aug 3, 2023

STAT+: An inside look at PIPEs, the financing trend that has biotech abuzz

STAT+: An inside look at PIPEs, the financing trend tha...

Feb 29, 2024

STAT+: Taysha Gene Therapies’ plan to tackle rare diseases is crumbling

STAT+: Taysha Gene Therapies’ plan to tackle rare disea...

Sep 30, 2023